← blog

What peptide purity number is actually good enough?

There is no clinical purity standard for gray-market peptides. None. The number on a certificate of analysis is real chemistry, but "how pure is pure enough" has no reference answer, and the community has quietly filled that vacuum with floors that drift 5 to 10 points depending on who you ask.

The floors people quote, and where they come from

Vendors and their COAs default to 98%+ on HPLC as the "minimum acceptable." Buyers repeat it back. The analytical chemists who actually run the tests give a different frame: 100% is ideal, "good" starts around 96%, and the number by itself tells you almost nothing until you know what the rest of the sample is.

That is a 96 to 98+ spread with no authority arbitrating it. And it climbs. Some listings advertise 99.9%. On a gray-market vial that figure should raise suspicion, not confidence. Purity that clean is rare in real synthesis and rarely reported by reputable labs, so an unusually pristine number often means the COA was doctored rather than the peptide was perfect.

Purity measures one thing, and it is narrow

HPLC purity answers a single question: of the material in the vial, how much is the target compound. It does not confirm the compound is what the label says. That is mass spec, a separate test. It does not measure endotoxins, the bacterial byproducts behind the "fever after injection" reaction. That is a separate test again, and most vendor COAs skip it. And it does not tell you whether the peptide works. Testing verifies what is in the vial, never whether the protocol does anything.

So "98% pure" can be 98% of the wrong molecule. A man went viral after his skin darkened on supposed retatrutide. He was injecting Melanotan II. The purity line would have looked fine.

The real question is what the other few percent is

This is where the threshold framing breaks. Two vials both test 97%. In one, the missing 3% is benign residual solvent. In the other, it is heavy metals. Same number, very different risk. Telling those apart is an expert read, not a pass/fail line, which is exactly why no single percentage works as a standard.

The failure mode people underrate is dosing, not toxicity. If a vial is only 10% pure and the other 90% is unknown filler ("baby powder"), someone dosing off the label assumption can overdose by roughly 5x without knowing it. You cannot dose what you cannot quantify.

What to actually do with a purity number

Treat it as necessary, not sufficient.

  • A COA with only a purity line, no mass-spec identity, and no endotoxin result is a partial document. Purity alone is the easiest number to fake and the least useful in isolation.
  • 99.9% on a gray-market vial is a reason to slow down, not to buy.
  • The only way to know your specific vial is independent third-party testing on the lot you received. Janoshik, Finnrick, ACS, and Eurofins run these. Certipep runs mass spec plus NMR out of ETH Zurich. A full panel is around $300 a sample, which is why group-buy test splits exist.

None of this resolves into a magic cutoff, because there isn't one. Anyone quoting you a hard purity floor as if it were a clinical standard is quoting a community habit, not a reference. Know what the number measures, know what it leaves out, and verify the vial in front of you instead of trusting a number on a page you can't audit.

If you want the mechanics of that verification, start with how to vet a source, then what a third-party lab result actually proves and why most COAs are theater. More on the feed.

puritytestingcoasourcinghow-to-vet